Die Kardiologen und die Zukunft ihres Fachs

Intensive LDL-cholesterol lowering and inhibition of inflammation to further reduce cardiovascular risk?

Over recent decades, research into the causes and mechanisms driving the development of cardiovascular disease has rapidly evolved. In everyday real life, this translates into ever more targeted treatment strategies that can be adapted to each individual’s cardiovascular history and risk.  

Chagas heart disease

Chagas heart disease is becoming a worldwide health burden and represents a major cause of cardiovascular death in areas where it is endemic.

When the heart does not accelerate and you cannot run...

Atrioventricular block in the young is a rare condition. It is defined as congenital when diagnosed in utero, at birth or during the first month of life.

Forschungsförderung durch die Schweizerische Herzstiftung

Die Schweizerische Herzstiftung wurde 1967 ­gegründet und hat seither für die Herz­forschung in unserem Lande eine heraus­ragende Rolle gespielt.

Swiss cardiologist elected chairman of the Europen Society of Cardiology (ESC) congress programme committee